UY34841A - VIRUS INFECCIOSO DE SCHMALLENBERG DE cADN CLONADOS Y SUS USOS - Google Patents

VIRUS INFECCIOSO DE SCHMALLENBERG DE cADN CLONADOS Y SUS USOS

Info

Publication number
UY34841A
UY34841A UY0001034841A UY34841A UY34841A UY 34841 A UY34841 A UY 34841A UY 0001034841 A UY0001034841 A UY 0001034841A UY 34841 A UY34841 A UY 34841A UY 34841 A UY34841 A UY 34841A
Authority
UY
Uruguay
Prior art keywords
schmallenberg
infectious virus
sbv
clonates
cdna
Prior art date
Application number
UY0001034841A
Other languages
English (en)
Inventor
Nikolin Veljko
Stadler Konrad
Lischewski Axel
Brix Alexander
Jeffrey P Knittel
Katharina Hedwig Toepfer
Original Assignee
Boehringer Ingelheim Vetmed
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmed filed Critical Boehringer Ingelheim Vetmed
Publication of UY34841A publication Critical patent/UY34841A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/12011—Bunyaviridae
    • C12N2760/12022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/12011—Bunyaviridae
    • C12N2760/12041—Use of virus, viral particle or viral elements as a vector
    • C12N2760/12043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/12011—Bunyaviridae
    • C12N2760/12051—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La presente invención pertenece al campo de la salud animal y se refiere a una secuencia de ácido n ucleico que comprende el genoma completo de un virus infeccioso de Schmallenberg (SBV) de utilidad para estudiar viremia y enfermedades causadas por SBV en rumiantes y en el desarrollo de vacunas, agentes terapéuticos y diagnósticos para la preven ción, tratamiento y diagnosis de viremia y enfermedades causadas por SBV.
UY0001034841A 2012-06-01 2013-05-31 VIRUS INFECCIOSO DE SCHMALLENBERG DE cADN CLONADOS Y SUS USOS UY34841A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP12170630 2012-06-01

Publications (1)

Publication Number Publication Date
UY34841A true UY34841A (es) 2013-12-31

Family

ID=48537980

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001034841A UY34841A (es) 2012-06-01 2013-05-31 VIRUS INFECCIOSO DE SCHMALLENBERG DE cADN CLONADOS Y SUS USOS

Country Status (5)

Country Link
US (1) US9241960B2 (es)
EP (1) EP2855512B1 (es)
AR (1) AR091239A1 (es)
UY (1) UY34841A (es)
WO (1) WO2013178711A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112014029515A2 (pt) 2012-06-01 2017-07-25 Boehringer Ingelheim Vetmedica Gmbh vacina de vírus schmallenberg (sbv), métodos de produção e usos da mesma, virus schmallenberg, usos de seus antígenos e composição de matéria
EP2855512B1 (en) 2012-06-01 2018-02-28 Boehringer Ingelheim Vetmedica GmbH Genomic sequences of schmallenberg virus and uses thereof
ES2893282T3 (es) * 2019-05-10 2022-02-08 Pasteur Institut Un nuevo orthobunyavirus en la encefalitis humana y su diagnóstico y aplicaciones terapéuticas
CN115057925B (zh) * 2022-06-22 2024-03-26 中国检验检疫科学研究院 一种抗赤羽病病毒单克隆抗体及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080226682A1 (en) 2007-03-13 2008-09-18 Peros Systems Technologies, Inc. Immunoactive Compositions for Improved Oral Delivery of Vaccines and Therapeutic Agents
BR112014029515A2 (pt) 2012-06-01 2017-07-25 Boehringer Ingelheim Vetmedica Gmbh vacina de vírus schmallenberg (sbv), métodos de produção e usos da mesma, virus schmallenberg, usos de seus antígenos e composição de matéria
EP2855512B1 (en) 2012-06-01 2018-02-28 Boehringer Ingelheim Vetmedica GmbH Genomic sequences of schmallenberg virus and uses thereof

Also Published As

Publication number Publication date
EP2855512B1 (en) 2018-02-28
US20130323210A1 (en) 2013-12-05
WO2013178711A1 (en) 2013-12-05
AR091239A1 (es) 2015-01-21
EP2855512A1 (en) 2015-04-08
US9241960B2 (en) 2016-01-26

Similar Documents

Publication Publication Date Title
AR091316A1 (es) Moleculas de union humanas que se pueden unir y neutralizar a los virus de la influenza b y sus usos
UY34918A (es) Nuevos ácidos 5-aminotetrahidroquinolin-2-carboxílicos y su uso
UY33370A (es) Composiciones farmacéuticas comprendiendo un fármaco inhibidor de la DPP4 y de la pioglitazona, procedimientos de preparación y utilización
AR076570A1 (es) Moleculas de union humanas capaces de neutralizar el virus de la influenza h3n2 y usos de las mismas
EA201600476A1 (ru) Вариант вируса ppcc, клон кднк вируса ppcc европейского типа и их применение
DOP2014000170A (es) Compuestos de imidazopirrolidinona
UY33797A (es) Composiciones farmacéuticas para el tratamiento del vhc
BR112012032008A2 (pt) anticorpos s100a4 e usos terapêuticos do mesmo
MX350282B (es) Molecula de union que tiene actividad neutralizadora del virus de la influenza a, producida a partir de celulas b humanas.
GT201500005A (es) Composiciones de vacuna para la prevencion contra la infeccion por el virus del dengue
BR112013020743A2 (pt) composições e métodos para a terapia e diagnóstico de influenza
UY34420A (es) ?métodos de tratamiento del virus de la hepatitis c con que de gs-7977 y ribavirina, composiciones y usos"
BR112014000637A2 (pt) diagnóstico do mal de alzheimer
UY34841A (es) VIRUS INFECCIOSO DE SCHMALLENBERG DE cADN CLONADOS Y SUS USOS
CO7131387A2 (es) Composiciones y métodos de polipéptidos-complejo de quelato de oligonucleótido
CL2018000433A1 (es) Procedimientos para mejorar la salud de peces de cultivo.
CL2015003563A1 (es) Marcador para trastornos de la esfingomielinasa ácida y sus usos.
BR112015002549A2 (pt) regime de vacinação para proteger uma criança contra infecção ou doença causada por vírus sincicial respiratório, composição imunogênica ou pluralidade de composições imunogênicas, uso de uma composição imunogênica ou de uma pluralidade de composições imunogênicas
EA201401352A1 (ru) Вакцина против вируса шмалленберга (sbv), способы ее получения и применения
CO7071133A2 (es) Diaminopirimidinas utiles como inhibidores del virus sincicial respiratorio (rsv) humano
ZA201308672B (en) Diagnosis of respiratory tract infectious disease using blood specimens
BR112014028632A8 (pt) Composto, composição farmacêutica, e, método para preparar um composto
BR112015002984A2 (pt) composição, vacina para proteger um animal contra uma infecção com bactérias leptospira, e, uso de ácido cítrico.
CU20150019A7 (es) Rotavirus humanos modificados
BR112015003074A2 (pt) composição, vacina para proteger um animal contra uma infecção com bactérias leptospira, e, uso de ácido etilenodiaminatetra-acético.